Category: PSYCH STOCK NEWS

Three Psychedelic Presentations Available Now: Filament Health (FLHLF), NovaMind (NVMDF) and Wesana Health (WSNAF)

Presentations Recorded September 16th Replays Available. Sign up for free registration to view presentations. https://youtu.be/e0ccytXLcEo The replays...

Braxia Scientific Reports Q1, Up 80% From Expanding Clinic Patient Base

Braxia Scientific Reports First Quarter 2022 Financial Results; Company Achieves 80% Revenue Growth from Expanding Clinic Patient Base Revenue from four Canadian clinics increased 80.3% to $407,075 year-over-yearExceeding monthly...

MindMed (MNMD) and Liechti Lab Provide Results from their Psilocybin R&D Collaboration

NEW YORK, Sept. 23, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that Dr. Matthias...

Ehave (EHVVF) Appoints LA’s ‘Top Doc’ Dr. Rahul Dixit, to Its Medical Advisory Board

To Assist and Advise the Company on Human Trials Ehave Appoints Board-Certified Gastroenterologist And Licensed Physician Dr. Rahul Dixit To Its Medical Advisory Board

Delic (DELCF) to Acquire Ketamine Wellness Centers Inc, Becoming Largest Psychedelic Wellness Chain in United States

Retail Footprint to Include 12 Open Locations, with 15 Additional Clinics in Development, Ensures Accessibility to Millions with Affordable Treatments and Insurance Coverage National Presence Will Bring...

Greenbrook TMS (GBNH) Announces Increase to Bought Deal Financing to US$11.5 Million

TORONTO, September 22, 2021--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, is pleased...

Bright Minds Biosciences (BIMBF) Provides Scientific Update

Lead program, BMB-101, advances to IND-enabling toxicology studies with the aim of commencing human trials in 1H 2022 LIVE QUOTE

Small Pharma (DMTTF) Successfully Completes Phase I Clinical Trial Of DMT In Combination With Supportive Psychotherapy

Small Pharma's DMT-assisted therapy (SPL026) demonstrated to be well-tolerated and safe in psychedelic naïve volunteers Dataset generated from Phase I enables the selection of the optimal dose...
Most Popular

Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi Zuloff-Shani.

INTRO VIDEO https://youtu.be/-RQikn6O3qw?si=o_IBy9yTlmfNNvky Join Clearmind Medicine CEO, Adi Zuloff-Shani,...

1000 Days Without Alcohol: Here’s What Happened

No..we didn't give up drinking - at least not yet. But we RUMinate about it from time to time. At a dinner...

Startup Ketamine Clinic ‘Being Health’ Raises $5.4 Million

This startup is opening a mental health clinic that offers ketamine therapy. BusinessInsider got an exclusive look at the pitch deck it...